Luteinizing Hormone-Releasing Hormone (LHRH)-Targeted Treatment in Ovarian Cancer

Pallavi Nayak, Michela Varani, Anna Giorgio, Giuseppe Campagna, Donatella Caserta, Alberto Signore, Rafael Coveñas Rodríguez · 2025

Read Luteinizing Hormone-Releasing Hormone (LHRH)-Targeted Treatment in Ovarian Cancer by Pallavi Nayak, Michela Varani, Anna Giorgio, Giuseppe Campagna, Donatella Caserta, Alberto Signore, Rafael Coveñas Rodríguez (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12732757.txt.

Description

Pallavi Nayak and co-authors review hormone targeted treatment for ovarian cancer in a 2025 paper, based on the head byline. Ovarian cancer stays among the deadliest cancers of women, and better targeted options are needed. A hormone receptor tied to reproduction appears on most ovarian tumors, which makes it a hook for guided drug delivery.

The search covered work from 2000 to 2025 across four databases, splitting peptide drug carriers from nanoparticle systems. In lab and animal studies the guided drugs slowed tumor growth strongly and entered cells several fold better, with less body wide harm. Early human studies, though small, showed response or control in about half of patients.

Catalog record

CREATORPallavi Nayak, Michela Varani, Anna Giorgio, Giuseppe Campagna, Donatella Caserta, Alberto Signore, Rafael Coveñas Rodríguez
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE86 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12732757

Browse the full library · About the Tower of Babel